GlassScriptPhysician profile
Eric W Anderson
NPI 1538239645
$2,404.05
in general payments reported to CMS, 2019-2025
28 companies · $901 in 2025
The $901 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $176 · 2021: $72.62 · 2022: $243 · 2023: $519 · 2024: $176 · 2025: $901.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,575 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,575.10 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $454.21 | 2019-2025 | Axonics, General - Kidney Stone Disease, General - Bph |
| Astellas Pharma US INC | $327.39 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $278.76 | 2021-2023 | Prolaris |
| Axonics, INC. | $176.68 | 2022-2023 | Axonics |
| Urogen Pharma, INC. | $146.58 | 2025 | |
| Procept Biorobotics Corporation | $134.24 | 2025 | |
| Pfizer INC. | $124.74 | 2019-2025 | |
| Janssen Biotech, INC. | $74.04 | 2020-2025 | Erleada |
| 180 Medical, INC. | $69.56 | 2022-2025 | |
| Olympus America INC. | $66.57 | 2025 | Itind System |
| Immunitybio, INC. | $59.99 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $49.91 | 2023 | |
| Calyxo, INC. | $44.71 | 2024 | Cvac Aspiration System |
| Progenics Pharmaceuticals, INC. | $42.45 | 2023-2024 | Pylarify |
| Ferring Pharmaceuticals INC. | $36.36 | 2024-2025 | Adstiladrin |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $34.24 | 2022-2023 | |
| Convatec INC. | $34.00 | 2023 | |
| Ambu INC. | $32.30 | 2020 | |
| Amgen INC. | $31.19 | 2019 | |
| Telix Pharmaceuticals | $28.61 | 2024 | Illuccix |
| Therapeuticsmd, INC. | $26.38 | 2019 | |
| Neotract INC. | $22.60 | 2019 | |
| Merck Sharp & Dohme LLC | $22.38 | 2025 | Keytruda |
| Medtronic, INC. | $19.95 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $19.02 | 2021 | |
| Rgh Enterprises LLC | $17.92 | 2020 | |
| Allergan, INC. | $14.97 | 2019 | |
| Tactile Systems Technology INC | $14.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.